secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001493152-25-013133
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo updates on going private: Board to consider sale, merger, or other alternatives
--------------------------------------------------------------------------------

- Received inbound interest from potential financial and strategic partners after announcing going private on July 23, 2025.
- Board will review all strategic alternatives including going private, reverse stock split, asset sale, or merger.
- Company plans to hold special stockholder meeting to approve proposed reverse stock split while review continues.
- No assurance that process will result in a transaction; no deadline or definitive timetable set.
- Even if stockholders approve reverse stock split, Board could abandon it for any reason.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315225013133/0001493152-25-013133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315225013133/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer